From April 1, 2023 to June 30, 2023, the company has repurchased 57,335 shares, representing 1.82% for $0.13 million. With this, the company has completed the repurchase of 57,335 shares, representing 1.82% for $0.13 million under the buyback announced on January 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.85 USD | 0.00% | 0.00% | +28.47% |
Apr. 23 | Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment | CI |
Apr. 10 | Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+28.47% | 5.26M | |
-3.79% | 88.14B | |
+1.45% | 40.51B | |
-15.94% | 31.67B | |
+52.66% | 24.62B | |
-14.50% | 15.65B | |
-9.12% | 11.97B | |
-14.38% | 12.07B | |
-42.56% | 11.61B | |
+4.87% | 8.81B |
- Stock Market
- Equities
- SILO Stock
- News Silo Pharma, Inc.
- Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.